Revolution Medicines (RVMD) Non-cash Items (2018 - 2026)

Revolution Medicines has reported Non-cash Items for 9 years, with the latest figure at $288.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 60.36% year-over-year to $288.0 million; the trailing twelve-month figure through Mar 2026 stood at $288.0 million (up 60.36% YoY), and the FY2025 full-year result was $885.5 million, up 220.44% from the prior year.
• Non-cash Items for Q1 2026 stood at $288.0 million, down from $885.5 million in the prior quarter.
• The five-year high for Non-cash Items was $885.5 million in Q4 2025, with the low at $52.8 million in Q3 2022.
• Average Non-cash Items over 5 years is $174.6 million, with a median of $118.7 million recorded in 2024.
• Year-over-year, Non-cash Items gained 1.46% in 2022 and surged 220.44% in 2025.
• Tracing RVMD's Non-cash Items over 5 years: stood at $85.2 million in 2022, then jumped by 35.02% to $115.0 million in 2023, then surged by 140.27% to $276.3 million in 2024, then surged by 220.44% to $885.5 million in 2025, then tumbled by 67.48% to $288.0 million in 2026.
• The last three Non-cash Items figures came in at $288.0 million (Q1 2026), $885.5 million (Q4 2025), and $177.7 million (Q3 2025), per Business Quant data.

Peer Comparison